Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vitamin K and Cognition in Coronary Heart Disease (NutriCog)
Sponsor: Montreal Heart Institute
Summary
The purpose of this pilot study is to obtain a preliminary assessment of the effect of VK supplementation on cognitive performance and vascular function in adults with stable Coronary Heart Disease (CHD)
Official title: Vitamin K Supplementation to Improve Cognition of Patients With Coronary Heart Disease: a Randomized Controlled Pilot Study
Key Details
Gender
All
Age Range
60 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-03-17
Completion Date
2027-03
Last Updated
2025-03-04
Healthy Volunteers
No
Conditions
Interventions
Vitamin K
Participants receive 0.5 mg/day phylloquinone orally for 12 weeks
Placebo
Participants receive daily placebo for 12 weeks
Locations (1)
Montreal Heart Institute
Montreal, Quebec, Canada